Total IκBα, which is an NF-κB-activated gene, was also increased by 2.32-fold and 1.62-fold, respectively, indicating increased activity of the IKK/NF-κB pathway in KRAS-positive lung tumourspheres enriched for TIC activity. This evidence concerns the gene NFKB1 and medical procedure.